Stentys: Journal Of The American College of Cardiology Publication Shows Malapposition Influences Death From Early Stent Thrombosis

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

PRINCETON, N.J. & PARIS--(BUSINESS WIRE)--STENTYS (FR0010949404 — STNT), a medical technology company commercializing the world's first and only Self-Apposing® Stent for treating acute myocardial infarction (AMI), today announced the publication of an article in the Journal of the American College of Cardiology (JACC) entitled, "Causes of Early Stent Thrombosis in Patients Presenting with Acute Coronary Syndrome: An Ex Vivo Human Autopsy Study."

Help employers find you! Check out all the jobs and post your resume.

Back to news